Home/Filings/4/0001209191-09-049267

4//SEC Filing

CORCEPT THERAPEUTICS INC 4

Accession 0001209191-09-049267

$CORTCIK 0001088856operating

View on SEC.gov Company Profile

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 5:13 PM ET

Size

20.6 KB

Accession

0001209191-09-049267

Insider Transaction Report

Form 4

Period: 2009-10-16

CORCEPT THERAPEUTICS INCCORT

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC

10% Owner

Transactions

Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)

CHAMPSI FARAH

10% Owner

Transactions

Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total

ALTA BIOPHARMA PARTNERS II LP

10% Owner

Transactions

Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total

ALTA BIOPHARMA MANAGEMENT II LLC

10% Owner

Transactions

Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)

ALTA PARTNERS II INC

10% Owner

Transactions

Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total

DELEAGE JEAN

10% Owner

Transactions

Purchase
Common Stock
2009-10-16$1.38/sh+12,406$17,120→ 180,204 total(indirect: By Side Fund)
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+118,036$14,755→ 640,996 total
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)
Purchase
Common Stock
2009-10-16$1.38/sh+337,245$465,398→ 5,484,063 total
Purchase
Warrants (right to buy)
2009-10-16$0.13/sh+4,342$543→ 10,949 total(indirect: By Side Fund)
Exercise: $1.66From: 2009-10-16Exp: 2012-10-16→ Common Stock (118,036 underlying)

Footnotes (5)

[F1]Acquired from the Issuer pursuant to the Securities Purchase Agreement dated October 12, 2009.
[F2]This price is the result of $1.43 per share, pursuant to Securities Purchase Agreement dated October 12, 2009, less the cost of warrants.
[F3]These securities are held of record by Alta BioPharma Partners II, L.P. ("ABPII"). Alta BioPharma Management II, LLC ("ABMII") is the General Partner of ABPII. Jean Deleage and Farah Champsi are managing directors and Edward Penhoet is a director of ABMII and they exercise shared voting and investment power with respect to the shares owned by ABPII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extend of his or her proportionate pecuniary interest therein.
[F4]Mr. Edward Penhoet is a director of the Issuer and files separate reports pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
[F5]These securities are held of record by Alta Embarcadero BioPharma Partners II, LLC ("AEBPII"). Alta Partners II, Inc. ("APII") provides investment advisory services to ABPII and AEBPII. Jean Deleage and Farah Champsi are managers of AEBPII and exercise shared voting and investment power over the shares held by AEBPII. Each of the reporting persons disclaims beneficial ownership of all such shares except to the extend of his or her proportionate pecuniary interest therein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001088856

Filing Metadata

Form type: 4
Filed: Oct 19, 8:00 PM ET
Accepted: Oct 20, 5:13 PM ET
Size: 20.6 KB

View on SEC.gov